サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1466184

脳脊髄液（CSF）管理市場：世界の規模、シェア、動向分析、機会、予測レポート、2019-2030年

Cerebrospinal Fluid Management Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product; By End User; By Region

出版日
ページ情報
英文 400 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
脳脊髄液（CSF）管理市場：世界の規模、シェア、動向分析、機会、予測レポート、2019-2030年
出版日: 2024年04月12日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳脊髄液（CSF）管理の世界市場規模は2030年までに2倍以上の30億米ドルに拡大

世界の脳脊髄液（CSF）管理市場は、水頭症やその他の神経疾患による負担の増加、老年人口の増加により活況を呈しています。

戦略コンサルティングと市場調査の大手企業であるBlueWeave Consulting社は、最近の調査で、2023年の世界の脳脊髄液（CSF）管理市場規模を13億7,000万米ドルと推定しました。2024年から2030年にかけての予測期間において、脳脊髄液（CSF）管理の世界市場規模はCAGR 5.12%で拡大し、2030年には29億8,000万米ドルに達するとBlueWeaveは予測しています。髄膜炎、くも膜下出血、水頭症など、髄液に関連する疾患の発生率が上昇していることが、世界の脳脊髄液（CSF）管理市場を牽引する主な要因の1つです。さらに、世界の脳脊髄液（CSF）管理市場は、分析期間中、高齢者人口の増加とパーキンソン病やアルツハイマー病のような病気の発生率の増加によって牽引されると予測されています。

機会：新興諸国によるヘルスケア分野への投資拡大

インドやブラジルを含む主要な新興国は、患者数の増加や医療ツーリズムの活発化により、国全体の医療インフラを強化するため、医療分野への投資を活発化させています。発展途上国や低所得国における水頭症の有病率の高さは、主に社会経済的地位の低さと葉酸の補給不足に起因しています。その結果、脳脊髄液（CSF）管理に対する需要が増加し、市場全体を牽引すると予測されます。

地政学的緊張の高まりが世界の脳脊髄液（CSF）管理市場に与える影響

地政学的緊張の高まりは、世界の脳脊髄液（CSF）管理市場の成長にマイナスの影響を与えます。戦争、紛争、大量虐殺などの状況は、患者が適切なヘルスケアサービスを受けられるかどうかに影響し、医療品の不足を招きます。例えばロシアとイスラエルは、それぞれウクライナとパレスチナでいくつかの病院を破壊し、ヘルスケアシステム全体の崩壊と多くの医療従事者の離散を招いた。地政学的緊張に直面している他の多くの国々では、脳脊髄液（CSF）管理を行うための医療用品を入手する資源が限られており、これが世界市場の成長を制限しています。

世界の脳脊髄液（CSF）管理市場

セグメント別カバレッジ

脳脊髄液（CSF）管理の世界市場-エンドユーザー別

エンドユーザーに基づき、世界の脳脊髄液（CSF）管理市場は、小児、成人、老年に区分されます。小児の先天性水頭症有病率の増加により、小児セグメントが最も高い市場シェアを占めています。出生時から脳内に脳脊髄液（CSF）が過剰に存在すると、先天性水頭症になります。その結果、小児に行われるシャント手術の数も高い割合で増加しており、世界の脳脊髄液（CSF）管理市場を牽引しています。

脳脊髄液（CSF）管理の世界市場-地域別

この調査レポートは、世界の脳脊髄液（CSF）管理市場を詳細に調査し、主要5地域の国別市場を多数掲載しています：北米、欧州、アジア太平洋（APAC）、ラテンアメリカ、中東アフリカです。北米は世界の脳脊髄液（CSF）管理市場を独占しています。同市場における同地域の優位性は、主に高齢者人口の増加と神経障害の蔓延に起因しています。さらに、この分野における広範な研究開発活動と米国FDAによる新製品の承認は、予測期間にわたって脳脊髄液（CSF）管理市場の主要プレーヤーに有利な成長機会をもたらすと予測されています。

競合情勢

世界の脳脊髄液（CSF）管理市場で事業を展開する主要企業には、Medtronic Plc、B. Braun Melsungen AG、Integra Lifesciences、Natus Medical Incorporated、Sophysa、Aesculap AG、Spiegelberg GmbH &Co.KG、Moeller Medica、IRRAS AB、Argi Group、Sophysaです。

これらの企業は、市場シェアをさらに拡大するために、M&A、パートナーシップ、ジョイントベンチャー、ライセンス契約、新製品の発売など、さまざまな戦略を採用しています。

本レポートの詳細な分析により、成長の可能性、今後の動向、世界の脳脊髄液（CSF）管理市場に関する情報を提供します。また、総市場規模の予測を促進する要因も取り上げています。当レポートは、世界の脳脊髄液（CSF）管理市場における最近の技術動向や、意思決定者が適切な戦略的意思決定を行えるような業界洞察を提供することをお約束します。さらに、市場の成長促進要因・課題・競争力についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の脳脊髄液（CSF）管理市場の洞察

  • 業界バリューチェーン分析
  • DROC分析
    • 成長促進要因
      • 水頭症やその他の神経疾患の負担増加
      • 高齢化人口の増加
      • ヘルスケア意識の向上
      • 低侵襲ソリューションの採用拡大
    • 抑制要因
      • 処置と機器の高額な費用
      • 治療選択肢の認識不足
      • 熟練した専門家の不足
    • 機会
      • 低侵襲手術技術の進歩と新しい脳脊髄液ドレナージ装置の開発
      • 低侵襲手術に焦点を当てる
      • 遠隔医療と遠隔モニタリングをCSF管理デバイスと統合
    • 課題
      • 償還の課題
      • サイバーセキュリティの脅威
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の脳脊髄液（CSF）管理市場：マーケティング戦略

第5章 世界の脳脊髄液（CSF）管理市場、地域分析、2023年

  • 世界の脳脊髄液（CSF）管理市場、地域分析、2023年
  • 世界の脳脊髄液（CSF）管理市場、市場魅力度分析、2024～2030年

第6章 世界の脳脊髄液（CSF）管理市場概要

  • 市場規模と予測、2019-2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
      • 脳脊髄液シャント
      • 外部排水システム
    • エンドユーザー別
      • 小児科
      • 成人
      • 高齢者
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋（APAC）
      • ラテンアメリカ（LATAM）
      • 中東およびアフリカ（MEA）

第7章 北米の脳脊髄液（CSF）管理市場

  • 市場規模と予測、2019-2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第8章 欧州の脳脊髄液（CSF）管理市場

  • 市場規模と予測、2019-2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • その他

第9章 アジア太平洋地域の脳脊髄液（CSF）管理市場

  • 市場規模と予測、2019-2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリアとニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • その他

第10章 ラテンアメリカの脳脊髄液（CSF）管理市場

  • 市場規模と予測、2019-2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • その他

第11章 中東およびアフリカの脳脊髄液（CSF）管理市場

  • 市場規模と予測、2019-2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • その他

第12章 競合情勢

  • 主要プレーヤーとその提供内容のリスト
  • 世界の脳脊髄液（CSF）管理市場シェア分析、2023年
  • 経営パラメータによる競合ベンチマーキング
  • 主要な戦略的展開（合併、買収、提携など）

第13章 高まる地政学的緊張が世界の脳脊髄液（CSF）管理市場に与える影響

第14章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要人物、主要競合、連絡先、戦略展望、 SWOT分析）

  • Medtronic Plc
  • B. Braun Melsungen AG
  • Integra Lifesciences
  • Natus Medical Incorporated
  • Sophysa
  • Aesculap AG
  • Spiegelberg GmbH &Co. KG
  • Moeller Medica
  • IRRAS AB
  • Argi Grup
  • Sophysa
  • その他の主要企業

第15章 主要な戦略的提言

第16章 調査手法

図表

List of Figures

  • Figure 1 Global Cerebrospinal Fluid (CSF) Management Market Segmentation
  • Figure 2 Global Cerebrospinal Fluid (CSF) Management Market Value Chain Analysis
  • Figure 3 Company Market Share Analysis, 2023
  • Figure 4 Global Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 5 Global Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 6 Global Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 7 Global Cerebrospinal Fluid (CSF) Management Market Share, By Region, By Value, 2019-2030
  • Figure 8 North America Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 9 North America Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 10 North America Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 11 North America Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019-2030
  • Figure 12 United States Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 13 United States Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 14 United States Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 15 Canada Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 16 Canada Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 17 Canada Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 18 Europe Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 19 Europe Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 20 Europe Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 21 Europe Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019-2030
  • Figure 22 Germany Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 23 Germany Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 24 Germany Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 25 United Kingdom Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 26 United Kingdom Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 27 United Kingdom Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 28 Italy Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 29 Italy Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 30 Italy Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 31 France Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 32 France Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 33 France Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 34 Spain Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 35 Spain Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 36 Spain Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 37 Belgium Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 38 Belgium Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 39 Belgium Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 40 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 41 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Share, By Technology, By Value, 2019-2030
  • Figure 42 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 43 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 44 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 45 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Share, By Deployment, By Value, 2019-2030
  • Figure 46 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019-2030
  • Figure 47 China Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 48 China Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 49 China Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 50 India Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 51 India Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 52 India Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 53 Japan Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 54 Japan Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 55 Japan Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 56 South Korea Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 57 South Korea Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 58 South Korea Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 59 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 60 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 61 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 62 Indonesia Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 63 Indonesia Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 64 Indonesia Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 65 Malaysia Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 66 Malaysia Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 67 Malaysia Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 68 Singapore Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 69 Singapore Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 70 Singapore Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 71 Vietnam Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 72 Vietnam Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 73 Vietnam Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 74 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 75 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 76 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 77 Latin America Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 78 Latin America Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 79 Latin America Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 80 Latin America Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019-2030
  • Figure 81 Brazil Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 82 Brazil Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 83 Brazil Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 84 Mexico Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 85 Mexico Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 86 Mexico Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 87 Argentina Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 88 Argentina Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 89 Argentina Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 90 Peru Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 91 Peru Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 92 Peru Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 93 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 94 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Share, By Product By Value, 2019-2030
  • Figure 95 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 96 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 97 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 98 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 99 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019-2030
  • Figure 100 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 101 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 102 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 103 UAE Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 104 UAE Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 105 UAE Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 106 Qatar Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 107 Qatar Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 108 Qatar Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 109 Kuwait Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 110 Kuwait Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 111 Kuwait Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 112 Iran Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 113 Iran Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 114 Iran Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 115 South Africa Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 116 South Africa Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 117 South Africa Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 118 Nigeria Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 119 Nigeria Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 120 Nigeria Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 121 Kenya Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 122 Kenya Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 123 Kenya Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 124 Egypt Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 125 Egypt Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 126 Egypt Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 127 Morocco Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 128 Morocco Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 129 Morocco Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 130 Algeria Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 131 Algeria Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 132 Algeria Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030
  • Figure 133 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019-2030
  • Figure 134 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019-2030
  • Figure 135 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019-2030

List of Tables

  • Table 1 Global Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 2 Global Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 3 Global Cerebrospinal Fluid (CSF) Management Market Size, By Region, By Value, 2019-2030
  • Table 4 North America Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 5 North America Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 6 North America Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019-2030
  • Table 7 United States Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 8 United States Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 9 Canada Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 10 Canada Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 11 Europe Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 12 Europe Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 13 Europe Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019-2030
  • Table 14 Germany Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 15 Germany Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 16 United Kingdom Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 17 United Kingdom Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 18 Italy Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 19 Italy Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 20 France Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 21 France Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 22 Spain Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 23 Spain Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 24 Belgium Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 25 Belgium Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 26 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 27 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 28 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 29 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 30 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019-2030
  • Table 31 China Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 32 China Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 33 India Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 34 India Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 35 Japan Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 36 Japan Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 37 South Korea Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 38 South Korea Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 39 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 40 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 41 Indonesia Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 42 Indonesia Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 43 Malaysia Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 44 Malaysia Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 45 Singapore Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 46 Singapore Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 47 Philippines Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 48 Philippines Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 49 Vietnam Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 50 Vietnam Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 51 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 52 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 53 Latin America Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 54 Latin America Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 55 Latin America Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019-2030
  • Table 56 Brazil Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 57 Brazil Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 58 Mexico Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 59 Mexico Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 60 Argentina Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 61 Argentina Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 62 Peru Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 63 Peru Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 64 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 65 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 66 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 67 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019-2030
  • Table 68 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 69 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 70 UAE Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 71 UAE Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 72 Qatar Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 73 Qatar Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 74 Kuwait Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 75 Kuwait Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 76 Iran Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 77 Iran Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 78 South Africa Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 79 South Africa Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 80 Nigeria Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 81 Nigeria Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 82 Kenya Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 83 Kenya Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 84 Egypt Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 85 Egypt Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 86 Morocco Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 87 Morocco Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 88 Algeria Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 89 Algeria Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 90 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019-2030
  • Table 91 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019-2030
  • Table 92 Medtronic Plc Company Overview
  • Table 93 Medtronic Plc Company Overview
  • Table 94 B. Braun Melsungen AG Company Overview
  • Table 95 B. Braun Melsungen AG Company Overview
  • Table 96 Integra Lifesciences Company Overview
  • Table 97 Integra Lifesciences Company Overview
  • Table 98 Natus Medical Incorporated Company Overview
  • Table 99 Natus Medical Incorporated Company Overview
  • Table 100 Sophysa Company Overview
  • Table 101 Sophysa Company Overview
  • Table 102 Aesculap AG Company Overview
  • Table 103 Aesculap AG Company Overview
  • Table 104 Spiegelberg GmbH & Co. KG Company Overview
  • Table 105 Spiegelberg GmbH & Co. KG Company Overview
  • Table 106 Moeller Medica Company Overview
  • Table 107 Moeller Medica Company Overview
  • Table 108 IRRAS AB Company Overview
  • Table 109 IRRAS AB Company Overview
  • Table 110 Argi Grup Company Overview
  • Table 111 Argi Grup Company Overview
  • Table 112 Sophysa Company Overview
  • Table 113 Sophysa Company Overview
目次
Product Code: BWC24279

Global Cerebrospinal Fluid (CSF) Management Market Size Set to More Than Double Touching USD 3 Billion by 2030

Global Cerebrospinal Fluid (CSF) Management Market is flourishing because of the increasing burden of hydrocephalus and other neurological disorders and growing geriatric population.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Cerebrospinal Fluid (CSF) Management Market size at USD 1.37 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Cerebrospinal Fluid (CSF) Management Market size to expand at a CAGR of 5.12% reaching a value of USD 2.98 billion by 2030. The rising incidence of illnesses linked to CSF, such as meningitis, subarachnoid hemorrhage, and hydrocephalus, is one of the main driving reasons for the Global Cerebrospinal Fluid (CSF) Management Market. Furthermore, it is projected that the Global Cerebrospinal Fluid (CSF) Management Market will be driven by a growing elderly population and the increasing incidence of illnesses like Parkinson's and Alzheimer's during the period in analysis.

Opportunity: Growing investments in healthcare sector by developing countries

Major emerging economies, including India and Brazil, have been significantly investing in their healthcare sector to strengthen the healthcare infrastructure across their countries owing to an increasing patient pool and to boost medical tourism in their respective countries. The high prevalence of hydrocephalus in developing and lower-income countries is mainly attributed to low socioeconomic status and a lack of folic acid supplementation. As a result, the demand for cerebrospinal fluid (CSF) management is projected to grow, driving the overall market.

Impact of Escalating Geopolitical Tensions on Global Cerebrospinal Fluid (CSF) Management Market

The escalating geopolitical tensions negatively impact the growth of the Global Cerebrospinal Fluid (CSF) Management Market. Situations like war, conflicts, and genocide impact the patient's accessibility to proper healthcare services and result in a shortage of medical supplies. Russia and Israel, for instance, destroyed several hospitals in Ukraine and Palestine, respectively, which resulted in the breakdown of the entire healthcare system and the displacement of many healthcare workers. Many other countries that are facing geopolitical tensions have limited resources to acquire medical supplies for performing cerebrospinal fluid (CSF) management, which limits its global market growth.

Global Cerebrospinal Fluid (CSF) Management Market

Segmental Coverage

Global Cerebrospinal Fluid (CSF) Management Market - By End User

Based on the end user, the Global Cerebrospinal Fluid (CSF) Management Market is segmented into pediatric, adult, and geriatric. The pediatric segment accounts for the highest market share owing to the increasing prevalence of congenital hydrocephalus among children. Overabundance of cerebrospinal fluid (CSF) in the brain from birth results in congenital hydrocephalus. As a result, the number of shunt procedures performed on children is also rising at a high rate, driving the global cerebrospinal fluid (CSF) management market.

Global Cerebrospinal Fluid (CSF) Management Market - By Region

The in-depth research report on the Global Cerebrospinal Fluid (CSF) Management Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Cerebrospinal Fluid (CSF) Management Market. The region's dominance in the market is mainly attributed to the growing elderly population and the prevalence of nervous disorders. Furthermore, extensive research and development activities in this field and approvals of new products by the US FDA are anticipated to present lucrative growth opportunities to the major players in the Cerebrospinal Fluid (CSF) Management Market over the forecast period.

Competitive Landscape

Major players operating in the Global Cerebrospinal Fluid (CSF) Management Market include Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences, Natus Medical Incorporated, Sophysa, Aesculap AG, Spiegelberg GmbH & Co. KG, Moeller Medica, IRRAS AB, Argi Group, and Sophysa.

These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Cerebrospinal Fluid (CSF) Management Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Cerebrospinal Fluid (CSF) Management Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Cerebrospinal Fluid (CSF) Management Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Burden of Hydrocephalus and Other Neurological Disorders
      • 3.2.1.2. Growing Geriatric Population
      • 3.2.1.3. Increasing Healthcare Awareness
      • 3.2.1.4. Growing Adoption of Minimally Invasive Solutions
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Procedures and Devices
      • 3.2.2.2. Lack of Awareness of Treatment Options
      • 3.2.2.3. Dearth of Skilled Professionals
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancements in Minimally Invasive Surgical Techniques and Development of New CSF Drainage Devices
      • 3.2.3.2. Focus on Minimally Invasive Procedures
      • 3.2.3.3. Integration of Telemedicine and Remote Monitoring with CSF Management Devices
    • 3.2.4. Challenges
      • 3.2.4.1. Reimbursement Challenges
      • 3.2.4.2. Cybersecurity Threats
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Cerebrospinal Fluid (CSF) Management Market: Marketing Strategies

5. Global Cerebrospinal Fluid (CSF) Management Market, Geographical Analysis, 2023

  • 5.1. Global Cerebrospinal Fluid (CSF) Management Market, Geographical Analysis, 2023
  • 5.2. Global Cerebrospinal Fluid (CSF) Management Market, Market Attractiveness Analysis, 2024-2030

6. Global Cerebrospinal Fluid (CSF) Management Market Overview

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share and Forecast
    • 6.2.1. By Product
      • 6.2.1.1. CSF Shunts
      • 6.2.1.2. External Drainage Systems
    • 6.2.2. By End User
      • 6.2.2.1. Pediatric
      • 6.2.2.2. Adult
      • 6.2.2.3. Geriatric
    • 6.2.3. By Region
      • 6.2.3.1. North America
      • 6.2.3.2. Europe
      • 6.2.3.3. Asia Pacific (APAC)
      • 6.2.3.4. Latin America (LATAM)
      • 6.2.3.5. Middle East and Africa (MEA)

7. North America Cerebrospinal Fluid (CSF) Management Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End User
    • 7.2.3. By Country
      • 7.2.3.1. United States
      • 7.2.3.1.1. By Product
      • 7.2.3.1.2. By End User
      • 7.2.3.2. Canada
      • 7.2.3.2.1. By Product
      • 7.2.3.2.2. By End User

8. Europe Cerebrospinal Fluid (CSF) Management Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End User
    • 8.2.3. By Country
      • 8.2.3.1. Germany
      • 8.2.3.1.1. By Product
      • 8.2.3.1.2. By End User
      • 8.2.3.2. United Kingdom
      • 8.2.3.2.1. By Product
      • 8.2.3.2.2. By End User
      • 8.2.3.3. Italy
      • 8.2.3.3.1. By Product
      • 8.2.3.3.2. By End User
      • 8.2.3.4. France
      • 8.2.3.4.1. By Product
      • 8.2.3.4.2. By End User
      • 8.2.3.5. Spain
      • 8.2.3.5.1. By Product
      • 8.2.3.5.2. By End User
      • 8.2.3.6. Belgium
      • 8.2.3.6.1. By Product
      • 8.2.3.6.2. By End User
      • 8.2.3.7. Russia
      • 8.2.3.7.1. By Product
      • 8.2.3.7.2. By End User
      • 8.2.3.8. Rest of Europe
      • 8.2.3.8.1. By Product
      • 8.2.3.8.2. By End User

9. Asia Pacific Cerebrospinal Fluid (CSF) Management Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End User
    • 9.2.3. By Country
      • 9.2.3.1. China
      • 9.2.3.1.1. By Product
      • 9.2.3.1.2. By End User
      • 9.2.3.2. India
      • 9.2.3.2.1. By Product
      • 9.2.3.2.2. By End User
      • 9.2.3.3. Japan
      • 9.2.3.3.1. By Product
      • 9.2.3.3.2. By End User
      • 9.2.3.4. South Korea
      • 9.2.3.4.1. By Product
      • 9.2.3.4.2. By End User
      • 9.2.3.5. Australia & New Zealand
      • 9.2.3.5.1. By Product
      • 9.2.3.5.2. By End User
      • 9.2.3.6. Indonesia
      • 9.2.3.6.1. By Product
      • 9.2.3.6.2. By End User
      • 9.2.3.7. Malaysia
      • 9.2.3.7.1. By Product
      • 9.2.3.7.2. By End User
      • 9.2.3.8. Singapore
      • 9.2.3.8.1. By Product
      • 9.2.3.8.2. By End User
      • 9.2.3.9. Vietnam
      • 9.2.3.9.1. By Product
      • 9.2.3.9.2. By End User
      • 9.2.3.10. Rest of APAC
      • 9.2.3.10.1. By Product
      • 9.2.3.10.2. By End User

10. Latin America Cerebrospinal Fluid (CSF) Management Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End User
    • 10.2.3. By Country
      • 10.2.3.1. Brazil
      • 10.2.3.1.1. By Product
      • 10.2.3.1.2. By End User
      • 10.2.3.2. Mexico
      • 10.2.3.2.1. By Product
      • 10.2.3.2.2. By End User
      • 10.2.3.3. Argentina
      • 10.2.3.3.1. By Product
      • 10.2.3.3.2. By End User
      • 10.2.3.4. Peru
      • 10.2.3.4.1. By Product
      • 10.2.3.4.2. By End User
      • 10.2.3.5. Rest of LATAM
      • 10.2.3.5.1. By Product
      • 10.2.3.5.2. By End User

11. Middle East & Africa Cerebrospinal Fluid (CSF) Management Market

  • 11.1. Market Size & Forecast, 2019-2030
    • 11.1.1. By Value (USD Billion)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By End User
    • 11.2.3. By Country
      • 11.2.3.1. Saudi Arabia
      • 11.2.3.1.1. By Product
      • 11.2.3.1.2. By End User
      • 11.2.3.2. UAE
      • 11.2.3.2.1. By Product
      • 11.2.3.2.2. By End User
      • 11.2.3.3. Qatar
      • 11.2.3.3.1. By Product
      • 11.2.3.3.2. By End User
      • 11.2.3.4. Kuwait
      • 11.2.3.4.1. By Product
      • 11.2.3.4.2. By End User
      • 11.2.3.5. South Africa
      • 11.2.3.5.1. By Product
      • 11.2.3.5.2. By End User
      • 11.2.3.6. Nigeria
      • 11.2.3.6.1. By Product
      • 11.2.3.6.2. By End User
      • 11.2.3.7. Algeria
      • 11.2.3.7.1. By Product
      • 11.2.3.7.2. By End User
      • 11.2.3.8. Rest of MEA
      • 11.2.3.8.1. By Product
      • 11.2.3.8.2. By End User

12. Competitive Landscape

  • 12.1. List of Key Players and Their Offerings
  • 12.2. Global Cerebrospinal Fluid (CSF) Management Market Share Analysis, 2023
  • 12.3. Competitive Benchmarking, By Operating Parameters
  • 12.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

13. Impact of Escalating Geopolitical Tensions on Global Cerebrospinal Fluid (CSF) Management Market

14. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 14.1. Medtronic Plc
  • 14.2. B. Braun Melsungen AG
  • 14.3. Integra Lifesciences
  • 14.4. Natus Medical Incorporated
  • 14.5. Sophysa
  • 14.6. Aesculap AG
  • 14.7. Spiegelberg GmbH & Co. KG
  • 14.8. Moeller Medica
  • 14.9. IRRAS AB
  • 14.10. Argi Grup
  • 14.11. Sophysa
  • 14.12. Other Prominent Players

15. Key Strategic Recommendations

16. Research Methodology

  • 16.1. Qualitative Research
    • 16.1.1. Primary & Secondary Research
  • 16.2. Quantitative Research
  • 16.3. Market Breakdown & Data Triangulation
    • 16.3.1. Secondary Research
    • 16.3.2. Primary Research
  • 16.4. Breakdown of Primary Research Respondents, By Region
  • 16.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable